Allovir, Inc. Quarterly Current Income Tax Expense (Benefit) in USD from Q2 2019 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.
Summary
Allovir, Inc. annual/quarterly Current Income Tax Expense (Benefit) history and growth rate from Q2 2019 to Q1 2023.
  • Allovir, Inc. Current Income Tax Expense (Benefit) for the quarter ending March 31, 2023 was $0.000.
  • Allovir, Inc. Current Income Tax Expense (Benefit) for the twelve months ending March 31, 2023 was -$265K, a 126% decline year-over-year.
  • Allovir, Inc. annual Current Income Tax Expense (Benefit) for 2023 was -$126K, a 52.5% increase from 2022.
  • Allovir, Inc. annual Current Income Tax Expense (Benefit) for 2022 was -$265K, a 126% decline from 2021.
Current Income Tax Expense (Benefit), Trailing 12 Months (USD)
Current Income Tax Expense (Benefit), Quarterly (USD)
Current Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 -$265K $0 $0 Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-04
Q4 2022 -$265K -$465K -$1.47M -146% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 $1.21M $0 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.21M $200K +$200K Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $1.01M $0 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $1.01M $1.01M Oct 1, 2021 Dec 31, 2021 10-K 2023-02-15
Q3 2021 $0 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $0 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $0 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $0 $0 Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $0 $0 Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $0 Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q3 2019 $0 Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 $0 Apr 1, 2019 Jun 30, 2019 10-Q 2020-09-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.